timothy sykes logo
RKLB Stock Rallies As Contracts And Targets Jump Thumbnail

RKLB Stock Rallies As Contracts And Targets Jump

MATT MONACOUPDATED MAY. 22, 2026, 9:18 AM ET
Reviewed by Jack Kelloggand Fact-checked by Tim Sykes

Rocket Lab Corporation shares have been trading up by 4.48 percent after winning a significant new satellite launch contract.

Candlestick Chart

Live Update At 09:18:01 EDT: On Friday, May 22, 2026 Rocket Lab Corporation stock [NASDAQ: RKLB] is trending up by 4.48%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

RKLB has ripped higher over the past month, and the chart tells the story. At the end of April, Rocket Lab was closing near $78–$83. By 2026/05/20, the stock finished at $134.28, and even after a dip to $125.45 on 2026/05/21, RKLB is still up more than 50% from late April levels. That’s momentum.

The daily candles show a classic breakout run: a steady grind from the high $70s to the low $100s, then a volume-style spike move above $130 after the Q1 report and contract news. Intraday, the 5‑minute tape around $128–$131 shows tight trading, with buyers stepping in on every small dip. That’s constructive action, not a blow-off top—at least for now.

Fundamentally, RKLB is still losing money, but the top line is scaling fast. Revenue over the last year was about $601.8M, with Q1 at $200.3M alone, up 63.5% year over year. Gross margin sits near 34.4%, while EBIT margins remain negative, reflecting heavy R&D and build-out spending. For traders, that mix—strong growth, improving scale, but no profits yet—often fuels big trending moves and sharp reversals. Respect both.

Why Traders Are Watching RKLB Now

RKLB is turning from a “science project” into a real space infrastructure story, and traders are reacting. The core driver is execution. Rocket Lab’s Q1 2026 revenue of $200.3M, up 63.5% year over year, came with a record $2.2B backlog. That backlog includes its largest launch deal ever: eight launches locked in through 2029, plus a separate $190M Department of Defense hypersonic test contract. That is not story stock fluff; it is contracted work spread across years.

On top of that, CFRA highlighted more than 70 missions in RKLB’s backlog and expects a new annual launch record. It reiterated a Strong Buy and took its 12‑month target to $140. For context, the stock is currently trading in the mid‑$120s. Several other firms—Deutsche Bank, TD Cowen, Clear Street, Craig‑Hallum, Citizens, and New Street Research—also raised their price targets, in some cases up to $120, and kept or initiated Buy or Outperform ratings. The shared theme: Rocket Lab is the only scaled Western launch and space platform outside SpaceX, with Neutron as a major catalyst.

RKLB is also moving deeper into defense. A fresh $90M U.S. Space Force contract makes Rocket Lab the prime contractor for two geostationary satellites carrying its in‑house Heimdall space domain awareness payload on its Lightning bus. That’s its first GEO satellite production program and reinforces a vertically integrated model: design, build, integrate, and operate. For traders, this matters because defense work tends to be stickier and can support higher-margin space systems and operations revenue over time.

Still, this isn’t a straight‑line story. WallStreetBets attention has fueled violent premarket swings—7% rebounds after sharp drops, retracements after double‑digit rallies. There’s also insider activity: director Alexander R. Slusky sold 100,000 shares for about $11.8M on 2026/05/12, though he still controls 493,524 shares. That looks like partial profit-taking, not a full exit, but it reminds traders that insiders are aware of how far RKLB has run.

More Breaking News

Conclusion

For active traders, RKLB is a classic momentum name backed by real fundamentals. The stock price has more than doubled from late April lows as Rocket Lab stacked one catalyst after another: a 63.5% revenue surge, a $2.2B backlog, the largest launch contract in its history, a $190M hypersonic test deal, and a $90M U.S. Space Force GEO satellite program. The upcoming first Neutron flight, highlighted as a major catalyst, sits out front as the next event the market is likely to trade around.

At the same time, Wall Street has flipped more aggressively bullish on RKLB. CFRA’s $140 target, along with a cluster of upgrades and raised targets toward $120 from Deutsche Bank, TD Cowen, Clear Street, Craig‑Hallum, Citizens, and New Street Research, tells traders that big money is taking the story seriously. That kind of analyst alignment often supports trend trades, even if volatility stays high.

But none of this turns Rocket Lab into a safe, sleepy name. Margins are still negative, the valuation is rich, and social‑media chatter adds noise on every spike. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your preparation and discipline.” As millionaire penny stock trader and teacher Tim Sykes says, “Cut losses quickly, let profits ride, and don’t overtrade.”. For RKLB, that means treating it as a fast-moving trading vehicle: map support and resistance, know the catalysts, respect the downside, and always—always—cut losses quickly. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



How much has this post helped you?


Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”